Yin Zequn, Wang Xuerui, Yang Xiaoxiao, Chen Yuanli, Duan Yajun, Han Jihong
Department of Pharmacological Sciences, Key Laboratory of Metabolism and Regulation for Major Diseases of Anhui Higher Education Institutes, College of Food and Biological Engineering, Hefei University of Technology, Hefei,China.
Curr Mol Pharmacol. 2021;14(6):960-974. doi: 10.2174/1874467214999210111222918.
Salvia miltiorrhiza, a traditional Chinese medicine, also named Danshen in China, is widely used for the treatment of cardiovascular disease. It demonstrates multiple biological functions, such as anti-oxidative stress, anti-inflammation and anti-thrombosis. Diabetic angiopathy is one of the diabetic complications with macro- and microangiopathy. Macroangiopathy mainly occurs in arteries, while the microangiopathy mainly includes diabetic retinopathy and nephropathy. Many factors associated with diabetes, such as metabolic abnormalities and oxidative stress, can induce vascular lesions. These factors promote the accumulation of lipids as well as inflammatory cytokines, increase the production of extracellular cell-matrix, and impair endothelium functions, thereby leading to vascular dysfunction. This review attempts to summarize the progress of the studies of Salvia miltiorrhiza on diabetic angiopathy, including improving endothelial function, anti- oxidative stress, reducing the risk of vascular blockage, inhibiting inflammation as well as regulating lipid metabolism. We also summarize the pharmacological activity of bioactive components in Salvia miltiorrhiza and the delivery systems. We made the conclusion that Salvia miltiorrhiza can be used as a potential auxiliary drug for the treatment of diabetic angiopathy.
丹参是一种传统中药,在中国也被称为“Danshen”,广泛用于治疗心血管疾病。它具有多种生物学功能,如抗氧化应激、抗炎和抗血栓形成。糖尿病血管病变是糖尿病的并发症之一,包括大血管病变和微血管病变。大血管病变主要发生在动脉,而微血管病变主要包括糖尿病视网膜病变和肾病。许多与糖尿病相关的因素,如代谢异常和氧化应激,可导致血管病变。这些因素促进脂质和炎性细胞因子的积累,增加细胞外基质的产生,并损害内皮功能,从而导致血管功能障碍。本综述旨在总结丹参在糖尿病血管病变研究方面的进展,包括改善内皮功能、抗氧化应激、降低血管阻塞风险、抑制炎症以及调节脂质代谢。我们还总结了丹参中生物活性成分的药理活性及其给药系统。我们得出结论,丹参可作为治疗糖尿病血管病变的潜在辅助药物。